Skip to content

The Evaluation of Thiol Redox Status in Conjunctiva of Dry Eye Patients

The Evaluation of Thiol Redox Status in Conjunctiva of Dry Eye Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00718926
Enrollment
50
Registered
2008-07-21
Start date
2008-08-31
Completion date
2010-03-31
Last updated
2008-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry Eye Disease

Keywords

dry eye, Thiol redox, Oxidative stress

Brief summary

Dry eye disease is related with oxidative stress at the ocular surface. GSH is one of the key factor of protect from oxidative stress. To evaluate thiol status of ocular surface cells by monitoring GSH concentration, we can evaluate the severity of dry eye.

Detailed description

The conjunctival cells are collected by impression cytology. Those cells are stained with 100 mM of monochlorobimane (MCB, M-1381, Molecular Probes, Eugene, OR) and propidium iodide (PI). Fluorescent intensity, reflecting the amount of icGSH, was inspected under a confocal laser scan microscope. To detect the GSH levels we used a fluorescent MCB probe with excitation and emission wavelengths of 405 nm and 410-480 nm, respectively. The cell-permeating MCB probe is non-fluorescent but forms a fluorescent adduct with GSH in a reaction catalyzed by glutathione-S-transferase.

Interventions

None listed

Sponsors

Kyoto Prefectural University of Medicine
CollaboratorOTHER
Meiji University of Oriental Medicine
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* dry eye patients * control volunteers

Exclusion criteria

* Young (less than 20) patients * The patients who rejected this study

Design outcomes

Primary

MeasureTime frame
Tear amount, tear break up time, and so on are measured clinically. The thiol redox status is measured by staining the membrane.Once a month (totally 2-4 times) at the clinic

Countries

Japan

Contacts

Primary ContactJun Yamada, MD, PhD.
jyamada@koto.kpu-m.ac.jp+81-75-251-5663
Backup ContactNorihiko Yokoi, MD, PhD.
nyokoi@koto.kpu-m.ac.jp+81-75-251-5663

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026